💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Firms in Shenzhen nurse wounds after COVID 'war' - Chinese survey

Published 03/28/2022, 11:27 PM
Updated 03/29/2022, 01:30 AM
© Reuters. FILE PHOTO: A worker in a protective suit collects a swab from a resident at a residential compound under lockdown, following the coronavirus disease (COVID-19) outbreak in Shenzhen, Guangdong province, China March 14, 2022. Picture taken March 14, 2022.

BEIJING (Reuters) - China's manufacturing hub of Shenzhen is starting to get back on its feet after being hit by shutdowns in a recent COVID-19 outbreak, but many smaller firms worry about their near-term outlook, clouded by uncertain demand, Securities Times reported.

Shenzhen's recent "war" on COVID-19 has hurt up to 93% of the local small and medium-sized companies surveyed by the state-controlled newspaper, with many suffering production disruptions due to shutdowns, interruptions in supply chains, and delays in order executions.

Shenzhen allowed businesses and factories to restart operations on March 21 after authorities declared the latest outbreak had been brought under control.

The city, which has grappled with multiple outbreaks so far this year, conducted three rounds of mass testing in March after a spike in infections.

The outbreaks were modest by international standards, but Shenzhen authorities were swift to implement measures including business shutdowns under China's so-called "dynamic" zero-COVID policy.

In the Securities Times survey, 93% of the 97 companies that responded said the epidemic had raised their operating expenses, including labour, logistics and raw materials costs.

About half of them had 100 to 500 employees, while 26% commanded a labour force of over 500.

Compounding their woes, they said, has been difficulty in accessing financing.

More worrying than the short-term effect of the shutdowns is the long-term contraction in demand caused by the epidemic, the newspaper warned, citing a "profound" impact on Chinese demand from COVID-19.

Companies complained about changes in consumer behaviour from delays in surgical operations to purchases of new mobile phones.

Data on China's factory and services sector for March due out in coming days are expected to reflect the COVID-related pain.

The epicentre of China's COVID containment efforts has since moved to Shanghai, where the megacity of 26 million residents is facing its worst flare-up since China's initial 2020 outbreak.

Beijing has vowed to stabilise economic growth in a year when President Xi Jinping is expected in the autumn to secure a third term as leader in a once-in-five-years congress of the ruling Communist Party.

© Reuters. FILE PHOTO: A worker in a protective suit collects a swab from a resident at a residential compound under lockdown, following the coronavirus disease (COVID-19) outbreak in Shenzhen, Guangdong province, China March 14, 2022. Picture taken March 14, 2022. cnsphoto via REUTERS

"Although Beijing on some occasions has also called to minimise the economic cost of (its zero-COVID strategy), local government officials in practice have been ratcheting up mandatory mass testing and social distancing measures in fear of being accused of dereliction of duty," Nomura said.

"The consequence is that China's economy faces the most severe pressure since the spring of 2020."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.